// App-Quantinova.ai

P308 : NOVEL COPY NUMBER ABERRATION-BASED CLASSIFICATION METHODSREFINE RISK ASSESSMENT IN PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

Researchers

Presenter

  • G�bor Bedics

Principal Investigators

  • Blint Egyed

  • Lili Kotmayer

  • Karel de Groot

  • Szilvia Krizsn

  • Gbor Kovcs

  • Bla Kajtr

  • Gbor Ottffy

  • Anik Ujfalusi

  • Csongor Kiss

  • Zsuzsanna Jakab

  • Suvi Savola

  • Csaba Bdr

  • Dont Alpr

Medical Centers

  • Department of Paediatrics and Paediatric Health Care Center,Faculty of Medicine, University of Szeged,Szeged,Hongrie

  • Department of Pediatrics,University of Pécs Clinical Centre,Pécs,Hongrie

  • Department of Pediatrics,University of Pécs Clinical Centre,Pécs,Hongrie

  • Department of Pediatric Hematology-Oncology, Institute of Pediatrics,Faculty of Medicine, University of Debrecen,Debrecen,Ungarn

  • Department of Pediatrics,University of Pécs Clinical Centre,Pécs,Hongrie

  • Hemato-Oncology Unit,Heim Pál Children's Hospital,Budapest,Hungría

  • Hemato-Oncology Unit,Heim Pál Children's Hospital,Budapest,Hungría

  • Department of Pulmonology, Semmelweis University, Budapest, Hungary

  • Department of Paediatrics and Paediatric Health C

  • Department of Medicine, Medical University of Debrecen, Debrecen, Hungary

  • Department of Paediatrics and Paediatric Health Care Center,Faculty of Medicine, University of Szeged,Szeged,Hongrie

  • Central Hospital of Southern Pest - National Institute of Hematology a

  • Central Hospital of Southern Pest - National Institute of Hematology and Infectious Diseases,Budapest,Ungarn

  • Hungarian Childhood Cancer Registry,Hungarian Pediatric Oncology Network,Budapest,Ungarn

  • Hemato-Oncology Unit,Heim Pál Children's Hospital,Budapest,Hungría

  • Department of Oncogenetics,MRC Holland,

  • Hungarian Childhood Cancer Registry,Hungarian Pediatric Oncology Network,Budapest,Ungarn

  • MTA-SE Momentum Molecular Oncohematology Research Group, First Department of Pathology and Experimental Cancer Research,Semmelweis University,Budapest,Hungary

  • 2nd Department of Pediatrics,Semmelweis University,Budapest,

  • Department I

  • Department of Pathology,University of Pecs, Clinical Center,Pecs,Hungary

  • Hungarian Childhood Cancer Registry,Hungarian Pediatric Oncology Network,Budapest,Ungarn

  • Department of Pathology,University of Pecs, Clinical Center,Pecs,Hungary

  • Central Hospital of Southern Pest - National Institute of Hematology and Infectious Diseases,Budapest,Ungarn

  • Department of Medicine, Medical University of Debrecen, Debrecen, Hungary

  • Hungarian Childhood Cancer Registry,Hungarian Pediatric Oncology Network,Budapest,Ungarn

  • Department of Labora

  • Department of Pediatric Hematology-Oncology, Institute of Pediatrics,Faculty of Medicine, University of Debrecen,Debrecen,Ungarn

  • Department of Pediatric Hematology-Oncology, Institute of Pediatrics,Faculty of Medicine, University of Debrecen,Debrecen,Ungarn

  • MTA-SE Momentum Molecular Oncohematology Research Group, First Department of Pathology and Experimental Cancer Research,Semmelweis University,Budapest,Hungary

  • Hungarian Childhood Cancer Registry,Hung

  • Department of Oncogenetics,MRC Holland,Amsterdam,Niederlande

  • Department of Oncogenetics,MRC Holland,Amsterdam,Paesi Bassi

  • Department of Pathology,University of Pecs, Clinical Center,Pecs,Hungary

  • 2nd Department of Pediatrics,Semmelweis University,Budapest,

  • 2nd Department of Pediatrics,Semmelweis University,Budapest,

  • Department of Pathology,University of Pecs, Clinical Center,Pecs,Hungary

  • Department of Medicine, Medical University of Debrecen, Debrecen, Hungary

  • Department of Paediatrics and Paediatric Health Care Center,Faculty of Medicine, University of Szeged,Szeged,Hongrie

  • Department of Oncogenetics,MRC Holland,Amsterdam,Niederlande

  • 2nd Department of Pediatrics,Semmelweis University,Budapest,

  • Hemato-Oncology Unit,Heim Pál Children's Hospital,Budapest,Hungría

  • 2nd Department of Pediatrics,Semmelweis University,Budapest,

  • Hemato-Oncology Unit,Heim Pál Children's Hospital,Budapest,Hungría

  • Department of Hematology, Faculty of Medicine,University of Debrecen,Debrecen,Ungheria

  • Department of Oncogenetics,MRC Holland,Amsterdam,Paesi Bassi

  • Department of Oncogenetics,MRC Holland,Amsterdam,Niederlande

  • Department of Pathology,University of Pecs, Clinical Center,Pecs,Hungary

  • Department of Oncogenetics,MRC Holland,Amsterdam,Paesi Bassi

  • Department of Pediatrics,University of Pécs Clinical Centre,Pécs,Hongrie

  • Central Hospital of Southern Pest - National Institute of Hematology and Infectious Diseases,Budapest,Ungarn

  • Hemato-Oncology Unit,Heim Pál Children's Hospital,Budapest,Hungría

  • HCEMM-SU Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research,Se

  • Department of Pediatrics,University of Pécs Clinical Centre,Pécs,Hongrie

Locations

  • Hungary

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A